Summary
A new Medicare pilot program offering GLP-1 medications for weight loss at $50 a month is excluding some patients, like Jeff La Marca, who have pre-existing conditions such as severe obstructive sleep apnea. The program is designed only for those using the drugs solely for weight loss, routing patients with FDA-approved conditions for GLP-1 treatment back to their Part D plans, which can have much higher co-pays. This exclusion affects an estimated 5.9 million Medicare enrollees.